Skip to main content
SpringerLink
Log in

Silent Ischemia

  • Chapter
Cardiovascular Medicine

  • 238 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heberden W. Some account of a disorder of the breast. Med Trans Coll Physicians (Lond) 1772;2:59.

    Google Scholar 

  2. Enos WF, Holmes RH, Beyer J. Coronary artery disease among United States soldiers killed in action in Korea: preliminary report. JAMA 1953;152:1090.

    CAS  Google Scholar 

  3. Mason JK. Asymptomatic disease of coronary arteries in young men. Br Med J 1963;1234.

    Google Scholar 

  4. Monckeberg JG. Atherosklerose der Kombattanten (nach Obdurtionsbefunden). Zentralbl Herz Gefasskrankheiten 1915;7:10–22.

    Google Scholar 

  5. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction—silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol 1973;32:1–7.

    PubMed  CAS  Google Scholar 

  6. Sullivan W, Vlodaver Z, Tuna N, Long L, Edwards JE. Correlation of electrocardiographic and pathologic findings in healed myocardial infarction. Am J Cardiol 1978;42:724–732.

    PubMed  CAS  Google Scholar 

  7. Twiss A, Sokolow M. Angina pectoris: significant electrocardiographic changes following exercise. Am Heart J 1942;23:498–512.

    Google Scholar 

  8. Randich A, Maixner W. Interactions between cardiovascular and pain regulatory systems. Neurosci Biobehav Rev 1984;8:343–367.

    PubMed  CAS  Google Scholar 

  9. Falcone C, Auguadro C, Sconocchia R, Angoli L. Susceptibility to pain in hypertensive and normotensive patients with coronary artery disease: response to dental pulp stimulation. Hypertension 1997;30:1279–1283.

    PubMed  CAS  Google Scholar 

  10. Rosen SD, Paulesu E, Nihoyannopoulos P, et al. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124:939–949.

    PubMed  CAS  Google Scholar 

  11. Falcone C, Sconocchia R, Guasti L, Codega S, Montemartini C, Specchia G. Dental pain threshold and angina pectoris in patients with coronary artery disease. J Am Coll Cardiol 1988;12:348–352.

    PubMed  CAS  Google Scholar 

  12. Matsubara K, Yokota M, Miyahara T, Sobue T, Iwase M, Saito H. Left ventricular performance during exercise testing in patients with silent and symptomatic myocardial ischemia. Am Heart J 1995;129:459–464.

    PubMed  CAS  Google Scholar 

  13. Hikita H, Etsuda H, Takase B, Satomura K, Kurita A, Nakamura H. Extent of ischemic stimulus and plasma betaendorphin levels in silent myocardial ischemia. Am Heart J 1998;135:813–818.

    PubMed  CAS  Google Scholar 

  14. Marchant B, Umachandran V, Wilkinson P, Medbak S, Kopelman PG, Timmis AD. Reexamination of the role of endogenous opiates in silent myocardial ischemia. J Am Coll Cardiol 1994;23:645–651.

    PubMed  CAS  Google Scholar 

  15. Jarmukli NF, Ahn J, Iranmanesh A, Russell DC. Effect of raised plasma beta endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina. Heart 1999;82:204–209.

    PubMed  CAS  Google Scholar 

  16. Mazzone A, Cusa C, Mazzucchelli I, et al. Increased production of inflammatory cytokines in patients with silent myocardial ischemia. J Am Coll Cardiol 2001;38:1895–1901.

    PubMed  CAS  Google Scholar 

  17. Mazzone A, Mazzucchelli I, Vezzoli M, et al. Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia. J Am Coll Cardiol 2000;36:746–750.

    PubMed  CAS  Google Scholar 

  18. Falcone C, Auguadro C, Sconocchia R, et al. Susceptibility to pain during coronary angioplasty: usefulness of pulpal test. J Am Coll Cardiol 1996;28:903–909.

    PubMed  CAS  Google Scholar 

  19. Amsterdam EA, Wolfson S, Gorlin R. New aspects of the placebo response in angina pectoris. Am J Cardiol 1969;24:305–306.

    PubMed  CAS  Google Scholar 

  20. Friedman M, Breall WS, Goodwin ML, Sparagon BJ, Ghandour G, Fleischmann N. Effect of type A behavioral counseling on frequency of episodes of silent myocardial ischemia in coronary patients. Am Heart J 1996;132:933–937.

    PubMed  CAS  Google Scholar 

  21. Rutledge T, Linden W, Davies RF. Psychological risk factors may moderate pharmacological treatment effects among ischemic heart disease patients. Psychosom Med 1999;61:834–841.

    PubMed  CAS  Google Scholar 

  22. Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol 1997;29:756–763.

    PubMed  CAS  Google Scholar 

  23. Zellweger MJ, Weinbacher M, Zutter AW, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:33–40.

    PubMed  Google Scholar 

  24. Marcassa C, Galli M, Baroffio C, Campini R, Giannuzzi P. Ischemic burden in silent and painful myocardial ischemia: a quantitative exercise sestamibi tomographic study. J Am Coll Cardiol 1997;29:948–954.

    PubMed  CAS  Google Scholar 

  25. Elhendy A, Schinkel AFL, van Domburg RT, Bax JJ, Poldermans D. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi singlephoton emission computed tomography. Am J Cardiol 2003; 91:264–268.

    PubMed  Google Scholar 

  26. Klein J, Chao S, Bermand D, Rozanski A. Is “silent” ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994;89:1958–1966

    PubMed  CAS  Google Scholar 

  27. Hecht H, Shaw R, Bruce T, Myler R. Silent ischemia: evaluation by exercise and redistribution tomographic thallium-201 imaging. J Am Coll Cardiol 1989;14:895–900.

    PubMed  CAS  Google Scholar 

  28. Gasperetti C, Burwell L, Beller G. Prevalence and variables associated with silent myocardial ischemia on exercise thallium-201 stress testing. J Am Coll Cardiol 1990;16:115–123.

    PubMed  CAS  Google Scholar 

  29. Heller L, Tresgallo M, Sciacca R, Blood D, Seldin D, Johnson L. Prognostic significance of silent myocardial ischemia on thallium stress test. Am J Cardiol 1990;65:718–721.

    PubMed  CAS  Google Scholar 

  30. Mahmarian JJ, Pratt CM, Cocanougher MK, Verani MS. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography. Circulation 1990;82:1305–1315.

    PubMed  CAS  Google Scholar 

  31. Kurata C, Sajata K, Taguchi T, Kobayashi A, Yamazaki N. Exercise-induced silent myocardial ischemia: evaluation by thallium-201 emission computed tomography. Am Heart J 1990;119:557–67.

    PubMed  CAS  Google Scholar 

  32. Galli M, Bosimini E, Giordano A, Tavazzi L. Scintigraphic evidence of silent ischemia in post-MI patients: prognostic implication. Adv Cardiol 1990;37:244–260.

    PubMed  CAS  Google Scholar 

  33. Travin M, Flores A, Boucher C, Newell J, LaRaia P. Silent versus symptomatic ischemia during a thallium-201 exercise test. Am J Cardiol 1991;68:1600–1608.

    PubMed  CAS  Google Scholar 

  34. Hendler A, Greyson N, Robinson M, Freeman M. Patients with symptomatic ischemia have larger thallium perfusion abnormalities and more adverse prognosis than patients with silent ischemia. Can J Cardiol 1992;8:814–818.

    PubMed  CAS  Google Scholar 

  35. Bonow RO, Bacharach SL, Green MV, LaFreniere RL, Epstein SE. Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol 1987;60:778–783.

    PubMed  CAS  Google Scholar 

  36. Cohn PF, Brown EJ Jr, Wynne J, Holman BL, Atkins HL. Global and regional left ventricular ejection fraction abnormalities during exercise in patients with silent myocardial ischemia. J Am Coll Cardiol 1983;1:931–933.

    PubMed  CAS  Google Scholar 

  37. Vassiliadis IV, Machac J, O’Hara M, Sezhiyan T, Horowitz SF. Exercise-induced myocardial dysfunction in patients with coronary artery disease with and without angina. Am Heart J 1991;121:1403–1408.

    PubMed  CAS  Google Scholar 

  38. Vassiliadis IV, Fountos AI, Papadimitriou AG, Sbonias EC. Mental stress-induced silent myocardial ischemia detected during ambulatory ventricular function monitoring. Int J Card Imaging 1998;14:171–177.

    PubMed  CAS  Google Scholar 

  39. Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 1995;25:610–618.

    PubMed  CAS  Google Scholar 

  40. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974;23:105–111.

    PubMed  CAS  Google Scholar 

  41. Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997;30:171–179.

    PubMed  CAS  Google Scholar 

  42. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988;9:259–264.

    PubMed  CAS  Google Scholar 

  43. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993;22:1788–1794.

    PubMed  CAS  Google Scholar 

  44. Herlitz J, Bang A, Karlson BW. Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients. Cardiology 1996;87:423–428.

    PubMed  CAS  Google Scholar 

  45. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69–75.

    PubMed  CAS  Google Scholar 

  46. Stuckey TD, Stone GW, Cox DA, et al. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). Am J Cardiol 2005;95:1–7.

    PubMed  CAS  Google Scholar 

  47. Wackers FJT, Young LH, Inzucchi SE, et al. Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study. Diabetes Care 2004;27:1954–1961.

    PubMed  Google Scholar 

  48. Rutter MK, McComb JM, Brady S, Marshall SM. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. AJC 1999;83:27–31.

    CAS  Google Scholar 

  49. Rutter MK, Wahid ST, McComb JM, Marshall SM. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 2002;40:56–61.

    PubMed  CAS  Google Scholar 

  50. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110:22–26.

    PubMed  Google Scholar 

  51. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 1984;311:1144–1147.

    PubMed  CAS  Google Scholar 

  52. Chiariello M, Indolfi C, Cotecchia MR, Sifola C, Romano M, Condorelli M. Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 1985;110:529–534.

    PubMed  CAS  Google Scholar 

  53. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 1994;24:956–962.

    PubMed  CAS  Google Scholar 

  54. Nesto RW, Phillips RT, Kett KG, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170–175.

    PubMed  CAS  Google Scholar 

  55. Caracciolo EA, Chaitman BR, Forman SA, et al. Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation 1996;93:2097–2105.

    PubMed  CAS  Google Scholar 

  56. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J 2004;25:543–550.

    PubMed  Google Scholar 

  57. Masters AM, Geller AJ. Magnitude of silent coronary artery disease. NY State J Med 1964;64:2865.

    Google Scholar 

  58. Mark DB, Hlatky MA, Califf RM, et al. Painless exercise ST deviation on the treadmill long-term prognosis. J Am Coll Cardiol 1989;14:885–892.

    PubMed  CAS  Google Scholar 

  59. Weiner DA, Ryan TJ, McCabe CH, et al. Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia. A report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1988;81:428–436.

    Google Scholar 

  60. Golding B, Wolf E, Tzivoni D, Stern S. Transient S-T elevation detected by 24-hour ECG monitoring during normal daily activity. Am Heart J 1973;86:501–507.

    PubMed  CAS  Google Scholar 

  61. Deanfield JE, Ribiero P, Oakley K, Krikler S, Selwyn AP. Analysis of ST-segment changes in normal subjects: implications for ambulatory monitoring in angina pectoris. Am J Cardiol 1984;54:1321–1325.

    PubMed  CAS  Google Scholar 

  62. Cohn PF. Myocardial dysfunction in silent myocardial ischemia as demonstrated by ambulatory radionuclide left ventricular function studies. Cardiol Clin 1992;10:473–478.

    PubMed  CAS  Google Scholar 

  63. Legault SE, Freeman MR, Langer A, Armstrong PW. Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates. Br Heart J 1995;73:242–249.

    PubMed  CAS  Google Scholar 

  64. Taki J, Yasuda T, Tamaki N, et al. Temporal relation between left ventricular dysfunction and chest pain in coronary artery disease during activities of daily living. Am J Cardiol 1990;66:1455–1458.

    PubMed  CAS  Google Scholar 

  65. Deanfield JE, Shea M, Ribiero P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984;54:1195–1200.

    PubMed  CAS  Google Scholar 

  66. Deanfield JE, Maseri A, Selwyn AP, et al. Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 1983;2:753–758.

    PubMed  CAS  Google Scholar 

  67. Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro GM, Fazzini PF. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1983;1:934–939.

    PubMed  CAS  Google Scholar 

  68. Deanfield JE, Shea M, Kensett M, et al. Silent myocardial ischaemia due to mental stress. Lancet 1984;2:1001–1005.

    PubMed  CAS  Google Scholar 

  69. Shea MJ, Deanfield JE, deLandsheere CM, Wilson RA, Kensett M, Selwyn AP. Asymptomatic myocardial ischemia following cold provocation. Am Heart J 1987;114:469–476.

    PubMed  CAS  Google Scholar 

  70. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214–1219.

    PubMed  CAS  Google Scholar 

  71. Nademanee K, Intarachot V, Singh PN, Josephson MA, Singh BN. Characteristics and clinical significance of silent myocardial ischemia in unstable angina. Am J Cardiol 1986;58:26B–33B.

    PubMed  CAS  Google Scholar 

  72. Nademanee K, Intarachot V, Josephson MA, Rieders D, Vaghaiwalla MF, Singh BN. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987;10:1–9.

    PubMed  CAS  Google Scholar 

  73. Gerstenblith G. Treatment of unstable angina pectoris. Am J Cardiol 1992;70:32G–37G.

    PubMed  CAS  Google Scholar 

  74. Taylor GJ, Katholi RE, Womack K, Moses HW, Woods WT. Increased incidence of silent ischemia after acute myocardial infarction. JAMA 1992;268:1448–1450.

    PubMed  CAS  Google Scholar 

  75. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation 1994;89:1545–1556.

    Google Scholar 

  76. Drew BJ, Califf RM, Funk M, et al. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation 2004;110:2721–2746.

    PubMed  Google Scholar 

  77. Ostrander LDJ. The relation of “silent” T wave inversion to cardiovascular disease in an epidemiologic study. Am J Cardiol 1970;25:325–328

    PubMed  Google Scholar 

  78. Boon D, van Goudoever J, Piek JJ, van Montfrans GA. ST segment depression criteria and the prevalence of silent cardiac ischemia in hypertensives. Hypertension 2003;41:476–481.

    PubMed  CAS  Google Scholar 

  79. Thompson RC, Mackey DC, Lane GE, et al. Improved detection of silent cardiac ischemia with a 12-lead portable microprocessor-driven real-time electrocardiographic monitor. Mayo Clin Proc 1995;70:434–442.

    PubMed  CAS  Google Scholar 

  80. Mahmarian JJ, Steingart RM, Forman S, et al. Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators. J Am Coll Cardiol 1997;29:764–769.

    PubMed  CAS  Google Scholar 

  81. Quyyumi AA, Panza JA, Diodati JG, Callahan TS, Bonow RO, Epstein SE. Prognostic implications of myocardial ischemia during daily life in low risk patients with coronary artery disease. J Am Coll Cardiol 1993;21:700–708.

    PubMed  CAS  Google Scholar 

  82. Maas AC, Wyatt CM, Green CL, et al. Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction. Am Heart J 2004;147:698–704.

    PubMed  Google Scholar 

  83. Akkerhuis KM, Klootwijk PA, Lindeboom W, et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur Heart J 2001;22:1997–2006.

    PubMed  CAS  Google Scholar 

  84. Norgaard BL, Andersen K, Dellborg M, Abrahamsson P, Ravkilde J, Thygesen K. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. J Am Coll Cardiol 1999;33:1519–1527.

    PubMed  CAS  Google Scholar 

  85. Rozanski A, Bairey CN, Krantz DS, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005–1012.

    PubMed  CAS  Google Scholar 

  86. Deanfield JE, Shea MJ, Wilson RA, et al. Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. Am J Cardiol 1986;57:1005–1009.

    PubMed  CAS  Google Scholar 

  87. Campbell S, Barry J, Rocco MB, et al. Features of the exercise test that reflect the activity of ischemic heart disease out of hospital. Circulation 1986;74:72–80.

    PubMed  CAS  Google Scholar 

  88. Benhorin J, Moriel M, Gavish A, et al. Usefulness of severity of myocardial ischemia on exercise testing in predicting the severity of myocardial ischemia during daily activities. Am J Cardiol 1991;68:176–180.

    PubMed  CAS  Google Scholar 

  89. Borzak S, Fenton T, Glasser SP, et al. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS). J Am Coll Cardiol 1993;21:1605–1611.

    PubMed  CAS  Google Scholar 

  90. Benhorin J, Pinsker G, Moriel M, Gavish A, Tzivoni D, Stern S. Ischemic threshold during two exercise testing protocols and during ambulatory electrocardiographic monitoring. J Am Coll Cardiol 1993;22:671–677.

    PubMed  CAS  Google Scholar 

  91. Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990;82:1296–1304.

    PubMed  CAS  Google Scholar 

  92. Deedwania PC, Carbajal EV. Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life. Am J Cardiol 1992;70:19F–24F.

    PubMed  CAS  Google Scholar 

  93. Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395–400.

    PubMed  CAS  Google Scholar 

  94. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alteration with antianginal agents. Lancet 1988;2:755–759.

    PubMed  CAS  Google Scholar 

  95. Deedwania PC, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol 1990;65:1090–1096.

    PubMed  CAS  Google Scholar 

  96. Cohn PF, Lawson WE. Characteristics of silent myocardial ischemia during out-of-hospital activities in asymptomatic angiographically documented coronary artery disease. Am J Cardiol 1987;59:746–749.

    PubMed  CAS  Google Scholar 

  97. Brezinski DA, Tofler GH, Muller JE, et al. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation 1988;78:35–40.

    PubMed  CAS  Google Scholar 

  98. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514–1518.

    PubMed  CAS  Google Scholar 

  99. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet 1978;1:795–797.

    PubMed  CAS  Google Scholar 

  100. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315–1322.

    PubMed  CAS  Google Scholar 

  101. Hjalmarson A, Gilpin EA, Nicod P, et al. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267–275.

    PubMed  CAS  Google Scholar 

  102. Hansen O, Johansson BW, Gullberg B. Circadian distribution of onset of acute myocardial infarction in subgroups from analysis of 10,791 patients treated in a single center. Am J Cardiol 1992;69:1003–1008.

    PubMed  CAS  Google Scholar 

  103. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131–138.

    PubMed  CAS  Google Scholar 

  104. Davies RF, Habibi H, Klinke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol 1995;25:619–625.

    PubMed  CAS  Google Scholar 

  105. Mahmarian JJ, Moye LA, Verani MS, Bloom MF, Pratt CM. High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography. Am J Cardiol 1995;75:1116–1169.

    PubMed  CAS  Google Scholar 

  106. Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography. Am Heart J 1991;121:1361–1366.

    PubMed  CAS  Google Scholar 

  107. Mahmarian JJ, Fenimore NL, Marks GF, et al. Transdermal nitroglycerin patch therapy reduces the extent of exerciseinduced myocardial ischemia: results of a double-blind, placebocontrolled trial using quantitative thallium-201 tomography. J Am Coll Cardiol 1994;24:25–32.

    PubMed  CAS  Google Scholar 

  108. Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exerciseinduced myocardial ischemia. J Am Coll Cardiol 1997;30:125–130.

    PubMed  CAS  Google Scholar 

  109. Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998;98:2017–2023.

    PubMed  CAS  Google Scholar 

  110. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605–1614.

    PubMed  CAS  Google Scholar 

  111. Salustri A, Fioretti PM, McNeill AJ, Pozzoli MM, Roelandt JR. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. Eur Heart J 1992;13:1356–1362.

    PubMed  CAS  Google Scholar 

  112. Quinones MA, Verani MS, Haichin RM, Mahmarian JJ, Suarez J, Zoghbi WA. Exercise echocardiography versus 201Tl singlephoton emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients. Circulation 1992;85:1026–1031.

    PubMed  CAS  Google Scholar 

  113. Penfornis A, Zimmermann C, Boumal D, et al. Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabetic Medicine 2001;18:900–905.

    PubMed  CAS  Google Scholar 

  114. Elhendy A, Geleijnse ML, Roelandt JR, et al. Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test. Am J Cardiol 1995;75:1112–1115.

    PubMed  CAS  Google Scholar 

  115. Bigi R, Galati A, Curti G, et al. Different clinical and prognostic significance of painful and silent myocardial ischemia detected by exercise electrocardiography and dobutamine stress echocardiography after uncomplicated myocardial infarction. Am J Cardiol 1998;81:75–78.

    PubMed  CAS  Google Scholar 

  116. Krone RJ, Hardison RM, Chaitman BR, et al. Risk stratification after successful coronary revascularization: the lack of a role for routine exercise testing. J Am Coll Cardiol 2001;38:136–142.

    PubMed  CAS  Google Scholar 

  117. Mak KH, Eisenberg MJ, Tsang J, Okrainiec K, Huynh T, Brown DL. Clinical impact of functional testing strategy among stented and non-stented patients: insights from the ROSETTA Registry. Int J Cardiol 2004;95:321–327.

    PubMed  Google Scholar 

  118. Elhendy A, Shub C, McCully RB, Mahoney DW, Burger KN, Pellikka PA. Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. Am J Med 2001;111:18–23.

    PubMed  CAS  Google Scholar 

  119. Marwick TH, Case C, Short L, Thomas JD. Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography. Eur Heart J 2003;24:1223–1230.

    PubMed  Google Scholar 

  120. Laukkanen JA, Kurl S, Lakka TA, et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 2001;38:72–79.

    PubMed  CAS  Google Scholar 

  121. Sigurdsson E, Sigfusson N, Sigvaldason H, Thorgeirsson G. Silent ST-T changes in an epidemiologic cohort study—a marker of hypertension or coronary heart disease, or both: the Reykjavik study. J Am Coll Cardiol 1996;27:1140–1147.

    PubMed  CAS  Google Scholar 

  122. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125–1133.

    PubMed  Google Scholar 

  123. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J 2005;26:447–456.

    PubMed  Google Scholar 

  124. Cole JP, Ellestad MH. Significance of chest pain during treadmill exercise: correlation with coronary events. Am J Cardiol 1978;41:227–232.

    PubMed  CAS  Google Scholar 

  125. Callaham PR, Froelicher VF, Klein J, Risch M, Dubach P, Friis R. Exercise-induced silent ischemia: age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol 1989;14:1175–1180.

    PubMed  CAS  Google Scholar 

  126. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell’Infarto. Lancet 1995;346:523–529.

    PubMed  CAS  Google Scholar 

  127. Conti CR, Bourassa MG, Chaitman BR, et al. Asymptomatic cardiac ischemia pilot (ACIP). Trans Am Clin Climatol Assoc 1994;106:77–83.

    PubMed  CAS  Google Scholar 

  128. Conti CR, Geller NL, Knatterud GL, et al. Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators. Am J Cardiol 1997;79:889–892.

    PubMed  CAS  Google Scholar 

  129. Pancholy SB, Schalet B, Kuhlmeier V, Cave V, Heo J, Iskandrian AS. Prognostic significance of silent ischemia. J Nucl Cardiol 1994;1:434–440.

    PubMed  CAS  Google Scholar 

  130. Frishman WH, Glasser S, Stone P, Deedwania PC, Johnson M, Fakouhi TD. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. The AJC 1999;83:507–514.

    CAS  Google Scholar 

  131. Bandu I, Friedman H, Raggi P. Symptoms of patients with silent ischemia as detected by thallium stress testing. Chest 1994;105:1009–1012.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Baylor College of Medicine, Houston, TX, USA

    Matthew B. O’Steen MD

  2. Cardiac Catheterization Laboratory, Methodist DeBakey Heart Center, Houston, TX, USA

    Neal S. Kleiman MD

Authors
  1. Matthew B. O’Steen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neal S. Kleiman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Texas Health Science Center in Houston, Houston

    James T. Willerson MD (President, President-Elect and Medical Director) (President, President-Elect and Medical Director)

  2. Texas Heart Institute, Houston, TX, USA

    James T. Willerson MD (President, President-Elect and Medical Director) (President, President-Elect and Medical Director)

  3. Department of Cardiology, University of Maastricht, Masstricht, The Netherlands

    Hein J. J. Wellens MD (Emeritus Professor) (Emeritus Professor)

  4. Rasmussen Center for Cardiovascular Disease Prevention Cardiovascular Division, University of Minnesota, Minneapolis, MN, USA

    Jay N. Cohn MD (Professor of Medicine and Director) (Professor of Medicine and Director)

  5. Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA

    David R. Holmes Jr. MD (Consultant, Professor of Medicine and Scripps Professor) (Consultant, Professor of Medicine and Scripps Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

O’Steen, M.B., Kleiman, N.S. (2007). Silent Ischemia. In: Willerson, J.T., Wellens, H.J.J., Cohn, J.N., Holmes, D.R. (eds) Cardiovascular Medicine. Springer, London. https://doi.org/10.1007/978-1-84628-715-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-715-2_32

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-188-4

  • Online ISBN: 978-1-84628-715-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation